Au David J DJ - OmicsDI

Show results for

Unknown (39)
Genomics (9)
Metabolomics (1)
Proteomics (1)

Organisms

Homo sapiens (9)
Mus musculus (1)

Repository

EGA (9)
MetaboLights (1)
pride (1)

Tissue

Lung (1)

Disease

Long COVID (1)

Technology Type

Mass spectrometry (1)
Bottom-up proteomics (1)
Data-independent acquisition (1)
Mass Spectrometry (1)

Instrument Platform

Orbitrap Elite (Thermo Scientific) (1)

Publication Date

2017 (1)
2025 (1)

CHEBI ID

CHEBI:131654 (1)
CHEBI:131655 (1)
CHEBI:131658 (1)
CHEBI:131659 (1)
CHEBI:131660 (1)
CHEBI:131661 (1)
CHEBI:131662 (1)
CHEBI:131663 (1)
CHEBI:131665 (1)
CHEBI:131667 (1)
CHEBI:131668 (1)
CHEBI:131687 (1)
CHEBI:131688 (1)
CHEBI:131689 (1)
CHEBI:131690 (1)
CHEBI:131691 (1)
CHEBI:131692 (1)
CHEBI:131693 (1)
CHEBI:131694 (1)
CHEBI:131695 (1)
CHEBI:16919 (1)
CHEBI:17858 (1)
CHEBI:17933 (1)
CHEBI:18186 (1)
CHEBI:20000 (1)
CHEBI:27432 (1)
CHEBI:28940 (1)
CHEBI:34306 (1)
CHEBI:37998 (1)
CHEBI:52450 (1)

Metabolite Name

1-palmitoyl-2-(9,10-epoxystearoyl)phosphatidylcholine (1)
20-Hydroxyeicosatetraenoic acid (1)
25-Hydroxyvitamin-D3 (1)
2a-(Hydroxymethyl)-5a-androstane-3b,17b-diol (1)
3-Dehydroteasterone (1)
5,8,11-Eicosatriynoic acid (1)
8,11,14-Eicosatrien-5-ynoic acid (1)
9(cis)-retinal (Vitamin A) (1)
Acetylcarnitine (1)
Glycolithocholic acid (1)
LysoPC or PCc (PC(24:0/0:0)) (1)
LysoPC(20:4(5Z,8Z,11Z,14Z)) (1)
LysoPC(22:0) (1)
LysoPE(0:0/20:3(5Z,8Z,11Z)) (1)
MG(0:0/16:0/0:0) (1)
MG(18:1(9Z)/0:0/0:0) (1)
PAF C-18 (1)
PC(16:0/20:4(5Z,8Z,10E,14Z)(12OH[S])) (1)
PC(16:0/20:4(6E,8Z,11Z,14Z)(5OH[S])) (1)
PC(16:1(9Z)/2:0) (1)
PC(17:0/18:3(9Z,12Z,15Z)) (1)
PC(18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) (1)
PC(O-16:1(9Z)/2:0) (1)
PE(18:0/20:4(5Z,8Z,11Z,14Z)) (1)
PE(18:0/22:5(4Z,7Z,10Z,13Z,16Z)) (1)
PE(18:1(9Z)/0:0) (1)
PE(18:2((9Z,11Z)/18:2(9Z,11Z))[U] (1)
PE(18:2(9Z,12Z)/0:0) (1)
PE(20:2(11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (1)
PS(18:0/22:4(7Z,10Z,13Z,16Z)) (1)

Release Date

2021 (7)
2015 (5)
2025 (4)
2022 (4)
2013 (4)
2011 (3)
2024 (2)
2016 (2)
2014 (2)
2012 (2)
2026 (1)
2023 (1)
2020 (1)
2017 (1)

Lab affiliation

Head, Ubiquitin Signalling Division The Walter and Eliza Hall Institute of Medical Research 1G Royal Parade, Parkville 3052, VIC, Australia Professor, Department of Medical Biology University of Melbourne, 3010 Melbourne, VIC, Australia (1)

Previous page
1 / 5
You're on page 1
page 2
page 3
page 4
page 5
Next page

Sort by:

Relevance

Page size

Treatment of lean and diet-induced obesity (DIO) mice with a novel stable obestatin analogue alters plasma metabolite levels as detected by untargeted LC-MS metabolomics

Introduction: Obestatin is a controversial gastrointestinal peptide purported to have metabolic actions. Objectives: This study investigated whether treatment with a stable obestatin analogue (PEG-OB(Cys10, Cys13) changed plasma metabolite levels firstly in lean and subsequently in diet-induced obes...

2017-07-25 | MTBLS334 | MetaboLights

Treatment of sporadic inclusion body myositis with bimagrumab.

Not available

S-EPMC4277670 | biostudies-literature

Patient-reported quality of life and adherence outcomes after integrating exclusive liquid meal replacement in patients with head and neck cancer undergoing chemoradiation: results from a phase II study.

Not available

S-EPMC11747389 | biostudies-literature

Longitudinal analysis of ANA in the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort.

Not available

S-EPMC10066935 | biostudies-literature

PLpro inhibition protects in post-acute sequelae mouse model of COVID-19

The COVID-19 pandemic has highlighted how vulnerable a globally connected population is to the threat of newly emerging zoonotic viruses, exemplified by SARS-CoV-2. Despite considerable efforts to identify antivirals for coronaviruses (CoVs) in the last two decades, there exists only one FDA-approve...

ORGANISM(S): Mus musculus (Mouse)

2025-02-23 | PXD054356 | Pride